Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
Franceschi E, Bartolotti M, Paccapelo A, Marucci G, Agati R, Volpin L, Danieli D, Ghimenton C, Gardiman MP, Sturiale C, Poggi R, Mascarin M, Balestrini D, Masotto B, Brandes AA. Franceschi E, et al. Among authors: mascarin m. J Neurooncol. 2016 Jun;128(2):235-40. doi: 10.1007/s11060-016-2097-x. Epub 2016 Mar 3. J Neurooncol. 2016. PMID: 26940908
Patterns of domestic migrations and access to childhood cancer care centres in Italy: a report from the hospital based registry of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Dama E, Rondelli R, De Rosa M, Aricò M, Carli M, Bellani FF, Magnani C, Merletti F, Pastore G, Pession A; Italian Association of Pediatric Hematology and Oncology (AIEOP). Dama E, et al. Eur J Cancer. 2008 Oct;44(15):2101-5. doi: 10.1016/j.ejca.2008.07.023. Epub 2008 Aug 20. Eur J Cancer. 2008. PMID: 18722109
Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience.
Franchin G, Vaccher E, Talamini R, Politi D, Gobitti C, Minatel E, Lleshi A, Sartor G, Mascarin M, Rumeileh IA, Trovò MG, Barzan L. Franchin G, et al. Among authors: mascarin m. Oral Oncol. 2011 Sep;47(9):905-9. doi: 10.1016/j.oraloncology.2011.06.503. Epub 2011 Jul 23. Oral Oncol. 2011. PMID: 21783403
Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.
Cefalo G, Massimino M, Ruggiero A, Barone G, Ridola V, Spreafico F, Potepan P, Abate ME, Mascarin M, Garrè ML, Perilongo G, Madon E, Colosimo C, Riccardi R. Cefalo G, et al. Among authors: mascarin m. Neuro Oncol. 2014 May;16(5):748-53. doi: 10.1093/neuonc/not320. Epub 2014 Jan 30. Neuro Oncol. 2014. PMID: 24482446 Free PMC article. Clinical Trial.
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA, Bartolotti M, Marucci G, Ghimenton C, Agati R, Fioravanti A, Mascarin M, Volpin L, Ammannati F, Masotto B, Gardiman MP, De Biase D, Tallini G, Crisi G, Bartolini S, Franceschi E. Brandes AA, et al. Among authors: mascarin m. Crit Rev Oncol Hematol. 2015 Jun;94(3):348-59. doi: 10.1016/j.critrevonc.2014.12.016. Epub 2014 Dec 31. Crit Rev Oncol Hematol. 2015. PMID: 25600839 Review.
Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.
Massimino M, Miceli R, Giangaspero F, Boschetti L, Modena P, Antonelli M, Ferroli P, Bertin D, Pecori E, Valentini L, Biassoni V, Garrè ML, Schiavello E, Sardi I, Cama A, Viscardi E, Scarzello G, Scoccianti S, Mascarin M, Quaglietta L, Cinalli G, Diletto B, Genitori L, Peretta P, Mussano A, Buccoliero A, Calareso G, Barra S, Mastronuzzi A, Giussani C, Marras CE, Balter R, Bertolini P, Giombelli E, La Spina M, Buttarelli FR, Pollo B, Gandola L. Massimino M, et al. Among authors: mascarin m. Neuro Oncol. 2016 Oct;18(10):1451-60. doi: 10.1093/neuonc/now108. Epub 2016 May 18. Neuro Oncol. 2016. PMID: 27194148 Free PMC article. Clinical Trial.
Pediatric intracranial ependymoma: correlating signs and symptoms at recurrence with outcome in the second prospective AIEOP protocol follow-up.
Massimino M, Barretta F, Modena P, Giangaspero F, Chiapparini L, Erbetta A, Boschetti L, Antonelli M, Ferroli P, Bertin D, Pecori E, Biassoni V, Garrè ML, Schiavello E, Sardi I, Viscardi E, Scarzello G, Mascarin M, Quaglietta L, Cinalli G, Genitori L, Peretta P, Mussano A, Barra S, Mastronuzzi A, Giussani C, Marras CE, Balter R, Bertolini P, Tornesello A, La Spina M, Buttarelli FR, Ruggiero A, Caldarelli M, Poggi G, Gandola L. Massimino M, et al. Among authors: mascarin m. J Neurooncol. 2018 Nov;140(2):457-465. doi: 10.1007/s11060-018-2974-6. Epub 2018 Aug 14. J Neurooncol. 2018. PMID: 30109673
110 results